Fresenius Kabi Lands Back on FDA’s Radar With Fresh Warning

Drugmaker Fresenius Kabi has caught the FDA’s attention again, this time receiving a warning letter for violations at its Maricao, Puerto Rico, blood bag manufacturing plant. Fresenius said Aug. 23 the warning stemmed from an April 2013 inspection of its subsidiary Fenwal.
Generic Line